Lipella Pharmaceuticals Common Stock Market Value
| LIPO Stock | 2.71 0.01 0.37% |
| Symbol | Lipella |
Lipella Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipella Pharmaceuticals. If investors know Lipella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipella Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.88) | Revenue Per Share | Quarterly Revenue Growth 0.279 | Return On Assets | Return On Equity |
The market value of Lipella Pharmaceuticals is measured differently than its book value, which is the value of Lipella that is recorded on the company's balance sheet. Investors also form their own opinion of Lipella Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lipella Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipella Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lipella Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipella Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipella Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipella Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lipella Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lipella Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lipella Pharmaceuticals.
| 02/11/2023 |
| 01/31/2025 |
If you would invest 0.00 in Lipella Pharmaceuticals on February 11, 2023 and sell it all today you would earn a total of 0.00 from holding Lipella Pharmaceuticals Common or generate 0.0% return on investment in Lipella Pharmaceuticals over 720 days. Lipella Pharmaceuticals is related to or competes with Senti Biosciences, Fennec Pharmaceuticals, Monopar Therapeutics, Ascletis Pharma, Transgene, Alpha Cognition, and ImmuCell. Lipella Pharmaceuticals is entity of United States More
Lipella Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lipella Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lipella Pharmaceuticals Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 46.17 | |||
| Value At Risk | (10.51) | |||
| Potential Upside | 12.55 |
Lipella Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lipella Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lipella Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Lipella Pharmaceuticals historical prices to predict the future Lipella Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.96) | |||
| Treynor Ratio | 0.0931 |
Lipella Pharmaceuticals Backtested Returns
Lipella Pharmaceuticals appears to be dangerous, given 3 months investment horizon. Lipella Pharmaceuticals has Sharpe Ratio of 0.033, which conveys that the firm had a 0.033 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Lipella Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Lipella Pharmaceuticals' Standard Deviation of 7.17, mean deviation of 4.81, and Risk Adjusted Performance of (0.01) to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Lipella Pharmaceuticals holds a performance score of 2. The company secures a Beta (Market Risk) of -2.06, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Lipella Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Lipella Pharmaceuticals is expected to outperform it. Please check Lipella Pharmaceuticals' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to make a quick decision on whether Lipella Pharmaceuticals' current price movements will revert.
Auto-correlation | 0.63 |
Good predictability
Lipella Pharmaceuticals Common has good predictability. Overlapping area represents the amount of predictability between Lipella Pharmaceuticals time series from 11th of February 2023 to 6th of February 2024 and 6th of February 2024 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lipella Pharmaceuticals price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current Lipella Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.63 | |
| Spearman Rank Test | 0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 2.56 |
Lipella Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Lipella Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lipella Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Lipella Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Lipella Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lipella Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lipella Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lipella Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lipella Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Lipella Pharmaceuticals Lagged Returns
When evaluating Lipella Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lipella Pharmaceuticals stock have on its future price. Lipella Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lipella Pharmaceuticals autocorrelation shows the relationship between Lipella Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Lipella Pharmaceuticals Common.
Regressed Prices |
| Timeline |
Pair Trading with Lipella Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lipella Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Lipella Stock
| 0.56 | MD | Mednax Inc | PairCorr |
| 0.52 | SEM | Select Medical Holdings | PairCorr |
| 0.31 | LFCR | Lifecore Biomedical | PairCorr |
| 0.31 | EHC | Encompass Health Corp Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Lipella Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lipella Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lipella Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lipella Pharmaceuticals Common to buy it.
The correlation of Lipella Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lipella Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lipella Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lipella Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Lipella Pharmaceuticals Correlation, Lipella Pharmaceuticals Volatility and Lipella Pharmaceuticals Alpha and Beta module to complement your research on Lipella Pharmaceuticals. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Lipella Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.